Submit a Release
Home
All
ESG
Health
Technology
Finance
Contributors
Sub Menu
Submit a Release
main-search-pop
Main menu
All
Results: 9937-9948 of 77307
Reju Secures €135 Million in Dutch NIKI Funding for Industrial-Scale Textile-to-Textile Regeneration Hub at Chemelot Industrial Park, the Netherlands
RevolKa Reimagines Antibody Engineering with "RevoAb®"
BYDFi Marks 6th Anniversary with Month-Long Celebration, Built for Reliability
Elliott Management Statement on Mitsui O.S.K. Lines, Ltd.
Iyuno Announces a Revolutionary Innovation in Global Content Localization and Beyond
Mountain Province Diamonds Announces Full Year and Fourth Quarter 2025 Results
Global Beauty Market Grows 10% as AI and E-commerce Reshape Consumer Buying
Lundin Mining Announces Updated Share Capital and Provides Update on Share Buybacks
BQool: Bringing Enterprise-Level Amazon AI Advertising Solutions to Growing Brands
Wegovy®▼(semaglutide injection) 2.4 mg recommended by NICE to reduce risk of major adverse cardiovascular events, including heart attacks and strokes, in adults with established cardiovascular disease and overweight or obesity (BMI ≥27 kg/m2)[1]
NJ Bio, Inc. and Ajinomoto Bio‑Pharma Services Enter into Collaboration to Strengthen Support for Antibody-Drug Conjugate Development
Electrolux Group ceases manufacturing in Chile
Prev
Page
1
2
…
828
829
830
…
6442
6443
Next
Page
